PHAR

Pharming Group NV is a pioneering specialty pharmaceutical company headquartered in Leiden, the Netherlands, that focuses on the development of innovative therapies for rare diseases and unmet medical needs globally. Leveraging its proprietary recombinant DNA technology, the company is dedicated to delivering safe and effective treatments, with an emphasis on enhancing patient outcomes. With a solid market presence in both the United States and Europe, Pharming is committed to addressing critical health challenges through its diverse pipeline and strategic collaborations, solidifying its role as a leader in the biopharmaceutical industry for rare disease therapies.